Iothalamate Meglumine bulk supplier for pharma manufacturers

Iothalamate Meglumine 282 mg/ml , 202 mg/ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 282 mg/ml , 202 mg/ml

Reference Brands: Conray (USA)

Iothalamate Meglumine is a Contrast Agent product available as Injection in strengths 282 mg/ml , 202 mg/ml. It corresponds to the reference brand Conray (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Iothalamic acid is an iodine-containing radiographic contrast agent marketed under the brand name Conray. It is supplied clinically in the form of its water-soluble salts, sodium iothalamate and meglumine iothalamate, which allow safe and effective administration during diagnostic imaging procedures. These formulations enhance radiographic visibility by absorbing X-rays, thereby improving visualization of anatomical structures and body cavities.

Iothalamic acid may be administered intravenously for imaging studies such as angiography and urography, or intravesically for direct instillation into the urinary bladder during specialized diagnostic procedures. Its pharmacokinetic profile enables rapid renal excretion, making it suitable for urinary tract imaging.

In addition to conventional contrast formulations, a radioactive form is available as sodium iothalamate I-125 injection, marketed under the brand name Glofil-125. This radiolabeled formulation is specifically indicated for the evaluation of glomerular filtration rate (GFR) and is used in the diagnosis and monitoring of patients with renal impairment or kidney disease.

Iothalamate Meglumine — third party manufacturing & bulk supply

Iothalamate Meglumine 282 mg/ml , 202 mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Iothalamate Meglumine is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Iothalamate Meglumine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Iothalamate Meglumine →

Back to Listing

Frequently Asked Questions

Iothalamate meglumine is used as an iodinated radiographic contrast agent to enhance visualization during diagnostic imaging procedures such as urography, angiography, and other X-ray–based examinations.

Iothalamate meglumine is composed of iothalamic acid combined with meglumine, forming a water-soluble iodinated compound suitable for injectable use in diagnostic imaging.

The most well-known trade name of iothalamate meglumine is Conray.

Iothalamate meglumine is manufactured by multiple pharmaceutical companies worldwide, depending on the brand owner and country-specific regulatory approvals.

The generic name of the product is iothalamate meglumine.

A commonly recognized brand name of iothalamate meglumine is Conray.

Iothalamate meglumine is manufactured in various countries including the USA, EU member states, and other regions, depending on the approved manufacturer and market authorization.